Connection

Armand Glassman to Prognosis

Back to Details
This is a "connection" page, showing publications Armand Glassman has written about Prognosis.
Armand Glassman
Connection Strength
0.199
Prognosis
  1. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2005 Apr 01; 158(1):88-91.
    View in: PubMed
    Score: 0.045
  2. Determination of secondary chromosomal aberrations of chronic myelocytic leukemia. Cancer Genet Cytogenet. 2004 Aug; 153(1):53-6.
    View in: PubMed
    Score: 0.043
  3. Cytogenetics as an aid in the diagnosis of lymphomas. Ann Clin Lab Sci. 2000 Jan; 30(1):72-4.
    View in: PubMed
    Score: 0.031
  4. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol. 2004 Mar; 121(3):402-7.
    View in: PubMed
    Score: 0.010
  5. Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: the clinical and pathologic spectrum. Leuk Lymphoma. 2002 Apr; 43(4):761-5.
    View in: PubMed
    Score: 0.009
  6. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood. 2002 Feb 01; 99(3):840-9.
    View in: PubMed
    Score: 0.009
  7. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenstr?m macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol. 2001 Oct; 116(4):543-9.
    View in: PubMed
    Score: 0.009
  8. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol. 2001 Apr; 115(4):571-81.
    View in: PubMed
    Score: 0.008
  9. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses. Am J Clin Pathol. 2000 Nov; 114(5):793-7.
    View in: PubMed
    Score: 0.008
  10. Prognostic value of cytogenetics in multiple myeloma. Br J Haematol. 1998 Apr; 101(1):189-94.
    View in: PubMed
    Score: 0.007
  11. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol. 1998 Mar; 16(3):1103-11.
    View in: PubMed
    Score: 0.007
  12. Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevance. Am J Hematol. 1997 Mar; 54(3):189-95.
    View in: PubMed
    Score: 0.006
  13. Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res Treat. 1996; 37(2):179-88.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.